CureVac - Ingmar Hoerr, CEO

1,223 مرتبہ دیکھا گیا
8.1
شکریہ، آپ کا ووٹ ریکارڈ کر لیا گیا ہے اور جلد ہی دکھا دیا جائے گا۔
ہاں
نہیں
آپ کے پروفائل بُک مارکس میں شامل کر دیا گیا ہے۔
ویڈیو کی تفصیل

CureVac, a clinical stage biopharmaceutical company from Tübingen, Germany, is pioneering the field of mRNA-based technology platforms for medical purposes with which mRNA is specifically optimised and formulated. Since 2000 the company develops novel mRNA-based cancer immunotherapies and prophylactic vaccines against infectious diseases – both under the brand RNActive®. CureVac has successfully established the first GMP (good manufacturing practice) facility worldwide for the manufacture of RNA and mRNA and has pioneered mRNA-based drugs in clinical studies.

تبصرے